Novartis leads list of 2012's 20 biggest spenders for R&D

03/12/2013 | Genetic Engineering & Biotechnology News

Novartis, Roche Holding and Merck topped this ranking of biopharmaceutical companies based on spending for research and development last year. Pfizer and Johnson and Johnson came in fourth and fifth, respectively. Also making the top 10 were Sanofi, GlaxoSmithKline, Eli Lilly and Co., AstraZeneca and Abbott Laboratories.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations